Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2007 1
2009 2
2013 1
2015 1
2016 2
2017 1
2018 1
2019 3
2021 4
2022 6
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients.
Jayk Bernal A, Gomes da Silva MM, Musungaie DB, Kovalchuk E, Gonzalez A, Delos Reyes V, Martín-Quirós A, Caraco Y, Williams-Diaz A, Brown ML, Du J, Pedley A, Assaid C, Strizki J, Grobler JA, Shamsuddin HH, Tipping R, Wan H, Paschke A, Butterton JR, Johnson MG, De Anda C; MOVe-OUT Study Group. Jayk Bernal A, et al. N Engl J Med. 2022 Feb 10;386(6):509-520. doi: 10.1056/NEJMoa2116044. Epub 2021 Dec 16. N Engl J Med. 2022. PMID: 34914868 Free PMC article. Clinical Trial.
Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial.
Wedemeyer H, Schöneweis K, Bogomolov P, Blank A, Voronkova N, Stepanova T, Sagalova O, Chulanov V, Osipenko M, Morozov V, Geyvandova N, Sleptsova S, Bakulin IG, Khaertynova I, Rusanova M, Pathil A, Merle U, Bremer B, Allweiss L, Lempp FA, Port K, Haag M, Schwab M, Zur Wiesch JS, Cornberg M, Haefeli WE, Dandri M, Alexandrov A, Urban S. Wedemeyer H, et al. Among authors: khaertynova i. Lancet Infect Dis. 2023 Jan;23(1):117-129. doi: 10.1016/S1473-3099(22)00318-8. Epub 2022 Sep 13. Lancet Infect Dis. 2023. PMID: 36113537 Clinical Trial.
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors.
Hammitt LL, Quinn D, Janczewska E, Pasquel FJ, Tytus R, Reddy KR, Abarca K, Khaertynova IM, Dagan R, Dawson R, McCauley J, Shekar T, Fu W, Pedley A, Sterling T, Tamms G, Musey L, Buchwald UK. Hammitt LL, et al. Among authors: khaertynova im. Hum Vaccin Immunother. 2023 Dec 31;19(1):2177066. doi: 10.1080/21645515.2023.2177066. Epub 2023 Mar 2. Hum Vaccin Immunother. 2023. PMID: 36864601 Free PMC article. Clinical Trial.
Urinary Clusterin Is Upregulated in Nephropathia Epidemica.
Martynova EV, Maksudova AN, Shakirova VG, Abdulkhakov SR, Khaertynova IM, Anokhin VA, Ivanova VV, Abiola IM, Garanina EE, Tazetdinova LG, Valiullina AH, Khaiboullina SF. Martynova EV, et al. Among authors: khaertynova im. Dis Markers. 2018 Feb 26;2018:8658507. doi: 10.1155/2018/8658507. eCollection 2018. Dis Markers. 2018. PMID: 29682100 Free PMC article.
Molnupiravir for the treatment of COVID-19 in immunocompromised participants: efficacy, safety, and virology results from the phase 3 randomized, placebo-controlled MOVe-OUT trial.
Johnson MG, Strizki JM, Brown ML, Wan H, Shamsuddin HH, Ramgopal M, Florescu DF, Delobel P, Khaertynova I, Flores JF, Fouche LF, Chang SC, Williams-Diaz A, Du J, Grobler JA, Paschke A, De Anda C. Johnson MG, et al. Among authors: khaertynova i. Infection. 2023 Oct;51(5):1273-1284. doi: 10.1007/s15010-022-01959-9. Epub 2023 Jan 17. Infection. 2023. PMID: 36648627 Free PMC article. Clinical Trial.
Long Term Immune Response Produced by the SputnikV Vaccine.
Martynova E, Hamza S, Garanina EE, Kabwe E, Markelova M, Shakirova V, Khaertynova IM, Kaushal N, Baranwal M, Rizvanov AA, Urbanowicz RA, Khaiboullina SF. Martynova E, et al. Among authors: khaertynova im. Int J Mol Sci. 2021 Oct 18;22(20):11211. doi: 10.3390/ijms222011211. Int J Mol Sci. 2021. PMID: 34681885 Free PMC article.
Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19.
Arribas JR, Bhagani S, Lobo SM, Khaertynova I, Mateu L, Fishchuk R, Park WY, Hussein K, Kim SW, Ghosn J, Brown ML, Zhang Y, Gao W, Assaid C, Grobler JA, Strizki J, Vesnesky M, Paschke A, Butterton JR, De Anda C. Arribas JR, et al. Among authors: khaertynova i. NEJM Evid. 2022 Feb;1(2):EVIDoa2100044. doi: 10.1056/EVIDoa2100044. Epub 2021 Dec 16. NEJM Evid. 2022. PMID: 38319178
Neutralizing Antibodies in COVID-19 Serum from Tatarstan, Russia.
Hamza S, Martynova E, Garanina E, Shakirova V, Bilalova A, Moiseeva S, Khaertynova I, Ohlopkova O, Blatt N, Markelova M, Khaiboullina S. Hamza S, et al. Among authors: khaertynova i. Int J Mol Sci. 2023 Jun 15;24(12):10181. doi: 10.3390/ijms241210181. Int J Mol Sci. 2023. PMID: 37373331 Free PMC article.
Antibody and T Cell Immune Responses to SARS-CoV-2 Peptides in COVID-19 Convalescent Patients.
Garanina E, Hamza S, Stott-Marshall RJ, Martynova E, Markelova M, Davidyuk Y, Shakirova V, Kaushal N, Baranwal M, Khaertynova IM, Rizvanov A, Foster TL, Khaiboullina S. Garanina E, et al. Among authors: khaertynova im. Front Microbiol. 2022 Apr 18;13:842232. doi: 10.3389/fmicb.2022.842232. eCollection 2022. Front Microbiol. 2022. PMID: 35509311 Free PMC article.
Serum Cytokine Alterations Associated with Age of Patients with Nephropathia Epidemica.
Shakirova V, Khaertynova I, Markelova M, Tarlinton R, Behnke J, Martynova E, Garanina E, Rizvanov A, Khaiboullina S. Shakirova V, et al. Among authors: khaertynova i. Biomed Res Int. 2022 Jan 11;2022:4685288. doi: 10.1155/2022/4685288. eCollection 2022. Biomed Res Int. 2022. PMID: 35059462 Free PMC article. Clinical Trial.
24 results